by Leanne Talbot | May 20, 2019
We are delighted to receive the news that we now have a 12th ENETs recognised Centre of Excellence in the UK. “It’s a wonderful achievement for the team at the Freeman Hospital to be accredited with the ENETs Centre of Excellence. We constantly strive to... by Leanne Talbot | May 20, 2019
On the 9th May the NET Patient Foundation Lung Neuroendocrine Cancer Project kicked off with the first meeting with our patient and supporter advisory group. We worked through the plans to provide adequate, relevant and up to date information for those newly... by Leanne Talbot | May 20, 2019
The Endocrine Society has accepted the NETest as a biomarker for microscopic liver disease (minimal residual disease) in neuroendocrine tumors for their thematic issue on Neuroendocrinology in 2019. The data identifies that “Emerging molecular liquid biopsies (e.g.,... by Leanne Talbot | May 8, 2019
NET Patient Foundation has 5 key pillars of activity focused on improving the lives of those affected by Neuroendocrine Cancer : Support, Education, Information, Advocacy and Research. As advocates we help raise the voice of patients, families and carers on healthcare... by Leanne Talbot | May 1, 2019
Each month we provide a roundup of announcements, news and updates. [npfButton size=“small” text=”Click here to read our April roundup” href=”https://www.neuroendocrinecancer.org.uk/wp-content/uploads/April-19-Monthly-Roundup.pdf”... by Leanne Talbot | Apr 30, 2019
The Index of Cancer Preparedness (ICP) looks at a wider range of elements that are relevant to cancer control. It presents data on 45 indicators relevant to specific parts of the prevention and care continuum, as well as to the wider context in which such efforts... 